Target halts sale of sports cards after fight breaks out “I would want to know what happened,” Moore said, “because it's of interest – not just from a sports fan perspective, although I like sports – it's of interest from the wider public health perspective to figure out what happened.” Which brings us back to that key question: Did all of the infected Yankees catch it from a shared, unvaccinated source, or did fully vaccinated individuals pass it to one another?
YANKEES COVID OUTBREAK UPDATE
In fact, as of Friday, the CDC will update its categorization to only count fully vaccinated patients who test positive for COVID as “breakthrough” cases if they’re hospitalized or die, which means the current Yankees cases wouldn’t even be tallied.īut because the Yankees have regimented, robust testing (Boone was tested at least three times Thursday), there’s a chance to better understand how COVID-19 spreads between vaccinated individuals. Cv8MTzC8Dtįor most people relying on vaccines to protect them from COVID-19 illness, hospitalization and death, the J&J is a perfectly viable option. The vaccines do not prevent COVID from entering the body, but it can dull the effects if it does. #Yankees GM Brian Cashman said that he believes this is proof that the vaccines work, since seven of their eight positive COVID-19 cases have not presented symptoms. Seven of the eight Yankees who tested positive have not experienced any symptoms and third-base coach Phil Nevin, the first person to test positive and the only one to feel sick, is now asymptomatic as well. Even in the case of the Yankees’ outbreak, the vaccine has proven valuable and effective at mitigating the severity. This is not to say that people who receive the J&J are at significantly more risk from COVID-19. In baseball, the case could be a preview of problems to come for other clubs that relaxed protocols after reaching the 85 percent threshold with J&J shots. “Again, if your goal is to keep your players on the field of play, that means you have to have negative testing, and you are more likely to get negative testing with the more potent vaccines.”
YANKEES COVID OUTBREAK TRIAL
“It's more likely that you will run into this problem with J&J vaccinated people than with mRNA vaccinated people because that's what the vaccine efficacy trial results show,” Moore said. Neuman stressed that in clinical trials even the J&J vaccine worked better with multiple doses and the decision to market a one-dose vaccine was more strategic (it adds a critical level of flexibility for vaccinating transient groups, rural populations, and homebound people.) For a baseball team whose operations depend on a clean slate of negative results, they would have recommended teams pursue one of the mRNA vaccines (Moderna and Pfizer), which have been shown to be 94.1 percent and 95 percent effective, according to the CDC. “And we know that these variants change the equation in terms of how well protected a person will be and how long that protection will last, because all the vaccines are made against the original 2019 version of the virus and the virus has been out there working hard and changing, improving itself out in the world,” said Neuman.īoth experts expressed concern that the Yankees received the Johnson & Johnson vaccine. Multiple more transmissible variants have circulated recently in New York City. Moore would also want to know precisely which sequence of the virus is circulating among the Yankees. “But, what would be unexpected is an infected J&J vaccine recipient then passing the infection on to someone else," Moore said.
(The CDC says that, in clinical trials, J&J was 66.3 percent effective at preventing positive COVID-19 tests). “It's not too unexpected that vaccine recipients will get asymptomatic or low-grade infection, particularly with J&J, because J&J is known to be 70 percent, approximately, effective at preventing mild disease,” he added.
0 kommentar(er)
